{
    "Trade/Device Name(s)": [
        "VITEK 2 AST - Yeast Fluconazole",
        "VITEK 2 AST-YS Fluconazole"
    ],
    "Submitter Information": "bioM\u00e9rieux, Inc.",
    "510(k) Number": "K133817",
    "Predicate Device Reference 510(k) Number(s)": [
        "K092454"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NGZ"
    ],
    "Summary Letter Date": "July 17, 2014",
    "Summary Letter Received Date": "July 18, 2014",
    "Submission Date": "December 13, 2013",
    "Regulation Number(s)": [
        "21 CFR 866.1640"
    ],
    "Regulation Name(s)": [
        "Antimicrobial susceptibility test powder",
        "Susceptibility Test Plate, Antifungal"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "mycology"
    ],
    "Analyte(s)": [
        "Fluconazole"
    ],
    "Specimen Type(s)": [
        "Isolated colonies"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "VITEK 2",
        "VITEK 2 Compact"
    ],
    "Method(s)/Technology(ies)": [
        "Minimum inhibitory concentration (MIC) microdilution",
        "Automated antimicrobial susceptibility testing"
    ],
    "Methodologies": [
        "Microdilution methodology",
        "Automated susceptibility testing"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Panel"
    ],
    "Document Summary": "FDA 510(k) summary for VITEK 2 AST - Yeast Fluconazole antifungal susceptibility testing assay for use with VITEK 2 systems.",
    "Indications for Use Summary": "Designed for antifungal susceptibility testing of Candida species as a quantitative test on VITEK 2 and VITEK 2 Compact Systems to determine in vitro susceptibility to antifungal agents.",
    "fda_folder": "Microbiology"
}